In the Original Investigation titled “Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial,”1 published online on November 24, 2021, in JAMA Dermatology, there were 2 minor errors in Table 1. The number of participants with 1 melanoma was adjusted from a total of 77 to 76, and for 3 melanomas, from 10 to 11. The respective percentages were adjusted as well. These changes did not affect the results of the data analysis. This article was corrected online.

1.Ackermann  DM, Dieng  M, Medcalf  E,  et al.  Assessing the potential for patient-led surveillance after treatment of localized melanoma (MEL-SELF): a pilot randomized clinical trial.   JAMA Dermatol. 2022;158(1):33-42. doi:10.1001/jamadermatol.2021.4704PubMedGoogle ScholarCrossref